Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Koyfman on Informing Patients of Reirradiation for Head and Neck Cancer

Shlomo Koyfman, MD
Published: Wednesday, Mar 22, 2017



Shlomo Koyfman, MD, associate staff, Radiation Oncology, Cleveland Clinic, discusses informing patients of reirradiation as a treatment for head and neck cancer.

Researchers at 8 institutions evaluated intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) to determine outcomes in the reirradiation setting for recurrent head and neck cancer.

With this study, there is now more information to better equip patients to make decisions about their treatment options, explains Koyfman. In addition to elaborating on what the modern outcomes are, being able to provide those prognostic subgroups is going to change the way physicians discuss reirradiation with their patients.
 


Shlomo Koyfman, MD, associate staff, Radiation Oncology, Cleveland Clinic, discusses informing patients of reirradiation as a treatment for head and neck cancer.

Researchers at 8 institutions evaluated intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) to determine outcomes in the reirradiation setting for recurrent head and neck cancer.

With this study, there is now more information to better equip patients to make decisions about their treatment options, explains Koyfman. In addition to elaborating on what the modern outcomes are, being able to provide those prognostic subgroups is going to change the way physicians discuss reirradiation with their patients.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication
x